GETNE Registration of Thyroid Cancer

Launched by GRUPO ESPANOL DE TUMORES NEUROENDOCRINOS · Dec 4, 2018

Keywords

ClinConnect Summary

The GETNE Registration of Thyroid Cancer trial is a research study looking at patients who have been diagnosed with thyroid cancer. This study aims to gather important information about different types of thyroid cancer, including differentiated, medullary, and anaplastic thyroid cancer. It will involve adults aged 18 and older who have had their diagnosis confirmed through medical testing. The goal is to better understand the experiences of these patients and how their cancer is treated.

To participate in this study, patients need to be 18 years or older, have a specific type of thyroid cancer confirmed by a doctor, and be willing to learn about the study and sign a consent form. Those under 18 or with other types of thyroid cancer that haven't been confirmed by medical tests will not be eligible. Participants can expect to provide information about their diagnosis and treatment, which will help researchers gain insights into thyroid cancer and improve care for future patients. If you or a loved one are considering joining, know that this study is actively recruiting and aims to enhance our understanding of thyroid cancer.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients older than 18 years with diagnosis of differentiated, medullary or anaplastic thyroid cancer confirmed by histopathology.
• • Patients who agree to participate and are able to understand the information sheet and sign the informed consent
• Exclusion Criteria:
• • Patients under 18 years of age.
• • Patients with other types of thyroid cancer or whose histopathological diagnosis has not been confirmed.
• • Patients who do not have the relevant basic information to be included in the study, according to the criteria of the principal investigator.